Definium Therapeutics, Inc.
Pharmaceutical company · New York, United States · Nasdaq: DFTX
Definium Therapeutics, Inc. is a pharmaceutical company headquartered in New York, United States. Its shares trade on Nasdaq under the ticker DFTX. It has reported private securities offerings to the US SEC, most recently $7 million sold in a notice filed in 2025.
Definium Therapeutics at a glance
What does Definium Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $7 million sold (2025).
Frequently asked questions about Definium Therapeutics
Where is Definium Therapeutics headquartered?
Definium Therapeutics, Inc. is headquartered in New York, United States.
What does Definium Therapeutics do?
Definium Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Medicinal Chemicals & Botanical Products.
Is Definium Therapeutics a public company?
Yes. Definium Therapeutics, Inc. trades on Nasdaq under the ticker DFTX.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences